Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
Zentalis Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 109 institutions reported holding Zentalis Pharmaceuticals, Inc., 66.1% of its shares. Largest: Vanguard, 5AM Venture Management, LLC and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Zentalis Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 4M | 5.6% | +1.01M | Aug 13, 2026 |
| 5AM Venture Management, LLC | 3.95M | 5.5% | no change | Aug 14, 2026 |
| BlackRock | 3.75M | 5.2% | +2.48M | Aug 7, 2026 |
| Squadron Capital Management LLC | 3.7M | 5.2% | +69,000 | Aug 14, 2026 |
| Two Sigma | 3.02M | 4.2% | +68,410 | Aug 14, 2026 |
| Acadian Asset Management LLC | 2.68M | 3.7% | −166K | Aug 13, 2026 |
| Citadel | 2.3M | 3.2% | +566K | Aug 14, 2026 |
| Renaissance Technologies | 1.61M | 2.2% | −329K | Aug 13, 2026 |
| Opaleye Management Inc. | 1.41M | 2.0% | no change | Aug 14, 2026 |
| Orbimed Advisors LLC | 1.39M | 1.9% | new | Aug 14, 2026 |